Autor: "Zetterberg, Henrik" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Pathophysiological subtypes of mild cognitive impairment due to Alzheimer's disease identified by CSF proteomics.
Autorzy:: Moutinho D; Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Mendes VM; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.
Caula A; LASIGE, Faculty of Sciences, University of Lisbon, 1649-028, Lisbon, Portugal.; Biocomputing Group, Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Madeira SC; LASIGE, Faculty of Sciences, University of Lisbon, 1649-028, Lisbon, Portugal.
Baldeiras I; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Guerreiro M; Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Cardoso S; Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Gobom J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, S-431 80, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-431 80, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, S-431 80, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, S-431 80, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.; Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin, University of Wisconsin-Madison, Madison, WI, 53792, USA.; UK Dementia Research Institute at UCL, London, WC1N 3BG, UK.
Santana I; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal.; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.; Department of Neurology, Hospital and University Centre of Coimbra, Coimbra, Portugal.
De Mendonça A; Faculty of Medicine, University of Lisbon, 1649-028, Lisbon, Portugal.
Aidos H; LASIGE, Faculty of Sciences, University of Lisbon, 1649-028, Lisbon, Portugal.
Manadas B; CNC - Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504, Coimbra, Portugal. .; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal. .; Pokaż więcej
Źródło:: Translational neurodegeneration [Transl Neurodegener] 2024 Apr 09; Vol. 13 (1), pp. 19. Date of Electronic Publication: 2024 Apr 09.
Typ publikacji:: Letter
MeSH Terms:: Alzheimer Disease*/complications
Alzheimer Disease*/diagnosis
Cognitive Dysfunction*/diagnosis
Humans ; Proteomics ; tau Proteins

Opinia redakcyjna

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Autorzy:: Swift IJ; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Rademakers R; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.; VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Finch N; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Baker M; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Ghidoni R; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy.
Benussi L; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy.
Binetti G; MAC-Memory Clinic and Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy.
Rossi G; Unit of Neurology V and Neuropathology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
Synofzik M; Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Wilke C; Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Mengel D; Division Translational Genomics of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; German Center of Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Graff C; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, BioclinicumKarolinska Institutet, Solna, Sweden.; Unit for Hereditary Dementias, Theme Inflammation and Aging, Karolinska University Hospital, Solna, Sweden.
Takada LT; Department of Neurology, Hospital das Clinicas, University of São Paulo Medical School, São Paulo, Brazil.
Sánchez-Valle R; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Antonell A; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Galimberti D; Dept. of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Fenoglio C; Dept. of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy.; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Serpente M; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Arcaro M; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Schreiber S; Department of Neurology, Otto Von Guericke University, Magdeburg, Germany.
Vielhaber S; Department of Neurology, Otto Von Guericke University, Magdeburg, Germany.
Arndt P; Department of Neurology, Otto Von Guericke University, Magdeburg, Germany.
Santana I; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.; Center for Neuroscience and Cell Biology, Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Almeida MR; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Moreno F; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain.
Barandiaran M; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain.
Gabilondo A; Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain.; Neuroscience Area, Biodonostia Health Research Insitute, San Sebastian, Gipuzkoa, Spain.
Stubert J; Department of Obstetrics and Gynecology, Rostock University Medical Center, Rostock, Germany.
Gómez-Tortosa E; Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
Agüero P; Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
Sainz MJ; Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.
Gohda T; Department of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Murakoshi M; Department of Nephrology, Faculty of Medicine, Juntendo University, Tokyo, Japan.
Kamei N; Department of Endocrinology and Metabolism, Hiroshima Red Cross Hospital & Atomicbomb Survivors Hospital, Hiroshima, Japan.; Institute for Clinical Research, National Hospital Organization, Kure Medical Center and Chugoku Cancer Center, Hiroshima, Japan.
Kittel-Schneider S; Department of Psychiatry, University College Cork, Cork, Ireland.; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital Würzburg, Würzburg, Germany.
Reif A; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital Frankfurt, Frankfurt, Germany.
Weigl J; Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, University Hospital Würzburg, Würzburg, Germany.; Department of Psychiatry, Hospital in Tauberbischofsheim, Tauberbischofsheim, Germany.
Jian J; University of Pennsylvania, Gene Therapy Program, Philadelphia, USA.
Liu C; Department of Orthopaedics & Rehabilitation, Yale University School of Medicine, New Haven, CT, USA.
Serrero G; A&G Pharmaceutical Inc, Columbia, MD, USA.; Program in Oncology, University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
Greither T; Center for Reproductive Medicine and Andrology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Theil G; Department of Urology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Lohmann E; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.; DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany.
Gazzina S; Department of Neurological and Vision Sciences, Neurophysiology Unit, ASST SpedaliCivili, Brescia, Italy.
Bagnoli S; Department of Neurological and Psychiatric Sciences, University of Florence, Viale Morgagni, 85, 50134, Florence, Italy.
Coppola G; Department of Neurology, University of California, Los Angeles, California, USA.; Department of Psychiatry Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, California, USA.
Bruni A; Regional Neurogenetic Centre, ASPCZ, Lamezia Terme, Italy.
Quante M; Department of Neonatology, Tuebingen University Hospital, Tuebingen, Germany.
Kiess W; Leipzig Research Center for Civilization Diseases - LIFE, University of Leipzig, Leipzig, Germany.; Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany.; Center of Pediatric Research (CPL), University of Leipzig, Leipzig, Germany.
Hiemisch A; Leipzig Research Center for Civilization Diseases - LIFE, University of Leipzig, Leipzig, Germany.; Center of Pediatric Research (CPL), University of Leipzig, Leipzig, Germany.
Jurkutat A; Leipzig Research Center for Civilization Diseases - LIFE, University of Leipzig, Leipzig, Germany.
Block MS; Department of Oncology, Mayo Clinic, Rochester, MN, USA.
Carlson AM; Department of Neurology, University of Colorado Anschutz Medical Campus, Denver, CO, USA.
Bråthen G; Department of Neurology and Clinical Neurophysiology, Trondheim University Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU. , Trondheim, Norway.
Sando SB; Department of Neurology and Clinical Neurophysiology, Trondheim University Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU. , Trondheim, Norway.
Grøntvedt GR; Department of Neurology and Clinical Neurophysiology, Trondheim University Hospital, Trondheim, Norway.; Department of Neuromedicine and Movement Science, Faculty of Medicine and Health Sciences, NTNU. , Trondheim, Norway.
Lauridsen C; Department of Research, Trondheim University Hospital, Trondheim, Norway.
Heslegrave A; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.
Heller C; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Abel E; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.
Gómez-Núñez A; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Puey R; Alzheimer's Disease and Other Cognitive Disorders Unit, FRCB-IDIBAPS, Institut de Neurociències, Neurology Service, Hospital Clínic de Barcelona, Universitat de Barcelona (UB), 08036, Barcelona, Spain.
Arighi A; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Rotondo E; Neurodegerative Diseases Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.
Jiskoot LC; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Meeter LHH; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Durães J; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.
Lima M; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.
Tábuas-Pereira M; Neurology Department, Centro Hospitalar E Universitário de Coimbra, Coimbra, Portugal.; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Lemos J; Faculty of Medicine, University of Coimbra, Coimbra, Portugal.
Boeve B; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Petersen RC; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Dickson DW; Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Graff-Radford NR; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
LeBer I; Sorbonne UniversitéInserm U1127, CNRS UMR 7225, Institut du Cerveau Et La Moelle Épinière (ICM), AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Sellami L; Sorbonne UniversitéInserm U1127, CNRS UMR 7225, Institut du Cerveau Et La Moelle Épinière (ICM), AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.; Centre de Référence Des Démences Rares Ou Précoces, IM2A, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Lamari F; UF de Biochimie Des Maladies Neurométaboliques Et Neurodégénératives, Service de Biochimie Métabolique, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France.
Clot F; UF de Neurogénétique Moléculaire Et Cellulaire, Département de Génétique, AP-HP, Hôpitaux Universitaires La Pitié Salpêtrière-Charles Foix, Paris, France.
Borroni B; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Cantoni V; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Rivolta J; Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Lleó A; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Fortea J; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Alcolea D; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Illán-Gala I; Neurology Department. Hospital Sant Pau, Memory Unit, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), 28031, Madrid, Spain.; Autonomous University of Barcelona, 08913, Barcelona, Spain.
Andres-Cerezo L; Institute of Rheumatology, Na Slupi 4, 12850, Prague 2, Prague, Czech Republic.
Van Damme P; Laboratory of Neurobiology, Flanders Interuniversity Institute for Biotechnology, Katholieke Universiteit Leuven, Campus Gasthuisberg, 3000, Louvain, Belgium.
Clarimon J; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.; Memory Unit, Department of Neurology, Institut d'Investigacions Biomèdiques Sant Pau - Hospital de Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
Steinacker P; Department of Neurology, Martin-Luther University Halle-Wittenberg, University Clinic Halle, Halle (Saale), Germany.
Feneberg E; Department of Neurology, Klinikum Rechts Der Isar, Technical University of Munich, Munich, Germany.
Otto M; Department of Neurology, Martin-Luther University Halle-Wittenberg, University Clinic Halle, Halle (Saale), Germany.
van der Ende EL; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
van Swieten JC; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Seelaar H; Department of Neurology and Alzheimer Center Erasmus MC, Erasmus MC University Medical Center, Rotterdam, Netherlands.
Zetterberg H; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at University College London, UCL Queen Square Institute of Neurology, University College London, London, UK.; Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, 43180, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.
Sogorb-Esteve A; Department of Neurodegenerative Disease, Dementia Research Institute, UCL Institute of Neurology, Queen Square, London, UK.; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK.
Rohrer JD; Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, Queen Square, London, WC1N 3BG, UK. .; Pokaż więcej
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2024 Mar 28; Vol. 16 (1), pp. 66. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Systematic Review; Journal Article
MeSH Terms:: Frontotemporal Dementia*/genetics
Frontotemporal Dementia*/pathology
Male ; Humans ; Female ; Progranulins/genetics ; Intercellular Signaling Peptides and Proteins/genetics ; Virulence ; Mutation/genetics ; Membrane Proteins/genetics ; Nerve Tissue Proteins/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer's Disease.
Autorzy:: Lantero-Rodriguez J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden. .
Salvadó G; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Snellman A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.; Turku PET Centre, University of Turku, Turku University Hospital, Turku, Finland.
Montoliu-Gaya L; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.
Brum WS; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.; Graduate Program in Biological Sciences: Biochemistry, Universidade Federal Do Rio Grande Do Sul (UFRGS), Porto Alegre, Brazil.
Benedet AL; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.
Mattsson-Carlgren N; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.; Department of Neurology, Skåne University Hospital, Lund, Sweden.; Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
Tideman P; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, 20502, Malmö, Sweden.
Janelidze S; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Palmqvist S; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Stomrud E; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, 20502, Malmö, Sweden.
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, Gothenburg, Sweden.; Department of Old Age Psychiatry, Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.; NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London, London, UK.; UK Dementia Research Institute, University College London, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience & Physiology, The Sahlgrenska Academy at the University of Gothenburg, House V3/SU, 43180, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Hansson O; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. .; Memory Clinic, Skåne University Hospital, 20502, Malmö, Sweden. .; Pokaż więcej
Źródło:: Molecular neurodegeneration [Mol Neurodegener] 2024 Feb 17; Vol. 19 (1), pp. 19. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*
Cognitive Dysfunction*
Humans ; tau Proteins ; Amyloid beta-Peptides ; Atrophy ; Biomarkers ; Disease Progression ; Positron-Emission Tomography

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Inflammatory biomarkers for neurobehavioral dysregulation in former American football players: findings from the DIAGNOSE CTE Research Project.
Autorzy:: van Amerongen S; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Alzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, Amsterdam, The Netherlands.; Amsterdam Neuroscience, Neurodegeneration, Amsterdam, The Netherlands.
Pulukuri SV; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Tuz-Zahra F; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
Tripodis Y; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.; Boston University Alzheimer's Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Cherry JD; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Boston University Alzheimer's Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; VA Boston Healthcare System, U.S. Department of Veteran Affairs, Boston, MA, USA.; Department of Veterans Affairs Medical Center, Bedford, MA, USA.; Department of Pathology and Laboratory Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Bernick C; Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, USA.
Geda YE; Department of Neurology and the Franke Global Neuroscience Education Center, Barrow Neurological Institute, Phoenix, AZ, USA.
Wethe JV; Department of Psychiatry and Psychology, Mayo Clinic School of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Katz DI; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Brain Injury Program, Encompass Health Braintree Rehabilitation Hospital, Braintree, MA, USA.
Alosco ML; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Boston University Alzheimer's Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.; Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Adler CH; Department of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Balcer LJ; Departments of Neurology, Population Health and Ophthalmology, NYU Grossman School of Medicine, New York, NY, USA.
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Institute of Psychiatry, Psychology and Neuroscience, King's College London, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Institute of Psychiatry, Psychology and Neuroscience, King's College London, Maurice Wohl Institute Clinical Neuroscience Institute, London, UK.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53792, USA.
Daneshvar DH; Department of Physical Medicine and Rehabilitation, Harvard Medical School, Boston, MA, USA.
Colasurdo EA; Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, WA, USA.
Iliff JJ; Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, WA, USA.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Li G; Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, WA, USA.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.; Education, and Clinical Center, Veterans Affairs Puget Sound Health Care System Geriatric Research, Seattle, WA, USA.
Peskind ER; Veterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, WA, USA.; Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Shenton ME; Psychiatry Neuroimaging Laboratory, Harvard Medical School, Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Boston, MA, USA.
Reiman EM; Banner Alzheimer's Institute, University of Arizona, Arizona State University, Translational Genomics Research Institute, and Arizona Alzheimer's Consortium, Phoenix, AZ, USA.
Cummings JL; Chambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, NV, USA.
Stern RA; Boston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. .; Boston University Alzheimer's Disease Research Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. .; Department of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. .; Departments of Neurosurgery, and Anatomy and Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. .; Pokaż więcej
Corporate Authors:: DIAGNOSE CTE Research Project Investigators
Źródło:: Journal of neuroinflammation [J Neuroinflammation] 2024 Feb 09; Vol. 21 (1), pp. 46. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:: Journal Article
MeSH Terms:: Chronic Traumatic Encephalopathy*/pathology
Football*
Brain Injuries, Traumatic*
Humans ; Aged ; Middle Aged ; Interleukin-6 ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Updating the study protocol: Insight 46 - a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development - phases 2 and 3.
Autorzy:: Murray-Smith H; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK. .
Barker S; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Barkhof F; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, Amsterdam, The Netherlands.; Centre for Medical Image Computing, University College London, London, UK.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Barnes J; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Brown TM; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Captur G; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
R E Cartlidge M; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Cash DM; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.; Centre for Medical Image Computing, University College London, London, UK.
Coath W; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Davis D; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Dickson JC; Institute of Nuclear Medicine, University College London Hospitals, London, UK.
Groves J; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Hughes AD; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
James SN; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Keshavan A; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Keuss SE; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
King-Robson J; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Lu K; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Malone IB; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Nicholas JM; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Rapala A; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Scott CJ; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.; Institute of Nuclear Medicine, University College London Hospitals, London, UK.
Street R; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Sudre CH; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.; Centre for Medical Image Computing, University College London, London, UK.; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Thomas DL; Neuroradiological Academic Unit, UCL Queen Square Institute of Neurology, University College London, London, UK.
Wong A; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Wray S; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Zetterberg H; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.; UK Dementia Research Institute, University College London, London, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Hong, Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Chaturvedi N; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Fox NC; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Crutch SJ; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.
Richards M; MRC Unit for Lifelong Health and Ageing at UCL, Department of Population Science & Experimental Medicine, UCL Institute of Cardiovascular Science, University College London, London, UK.
Schott JM; Dementia Research Centre, Queen Square Institute of Neurology, University College London, 1St Floor, 8-11 Queen Square, London, UK.; Pokaż więcej
Źródło:: BMC neurology [BMC Neurol] 2024 Jan 23; Vol. 24 (1), pp. 40. Date of Electronic Publication: 2024 Jan 23.
Typ publikacji:: Journal Article
MeSH Terms:: Dementia*
Aged ; Female ; Humans ; Male ; Aging ; Ambulatory Care ; Brain ; Observational Studies as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Biomarkers for neurodegeneration impact cognitive function: a longitudinal 1-year case-control study of patients with bipolar disorder and healthy control individuals.
Autorzy:: Knorr U; Department Frederiksberg, Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Nordre Fasanvej 57-59, 2000, Frederiksberg, Denmark. .; Department of Psychology, University of Copenhagen, Copenhagen, Denmark. .
Simonsen AH; Danish Dementia Research Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Zetterberg H; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, University College London, Queen Square, London, UK.; UK Dementia Research Institute University College London, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.
Blennow K; Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Willkan M; Section of Biostatistics, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
Forman J; Department of Psychology, University of Copenhagen, Copenhagen, Denmark.
Miskowiak K; Department Frederiksberg, Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Nordre Fasanvej 57-59, 2000, Frederiksberg, Denmark.; Department of Psychology, University of Copenhagen, Copenhagen, Denmark.
Hasselbalch SG; Danish Dementia Research Center, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Kessing LV; Department Frederiksberg, Copenhagen Affective Disorder Research Center (CADIC), Psychiatric Center Copenhagen, Nordre Fasanvej 57-59, 2000, Frederiksberg, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.; Pokaż więcej
Źródło:: International journal of bipolar disorders [Int J Bipolar Disord] 2024 Jan 16; Vol. 12 (1), pp. 2. Date of Electronic Publication: 2024 Jan 16.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathology.
Autorzy:: Therriault J; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Woo MS; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology, Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, 20251, Germany.
Salvadó G; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.
Gobom J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, S-431 80, Sweden.
Karikari TK; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, 15213, USA.
Janelidze S; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.
Servaes S; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Rahmouni N; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Tissot C; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Wallenberg Centre for Molecular Medicine, University of Gothenburg, Gothenburg, S-413 45, Sweden.; King's College London, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Institute Clinical Neuroscience Institute, London, SE5 9RT, UK.; NIHR Biomedical Research Centre for Mental Health and Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation, London, SE5 8AF, UK.
Benedet AL; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.
Montoliu-Gaya L; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.
Macedo AC; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Lussier FZ; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, 15213, USA.
Stevenson J; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.
Vitali P; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Friese MA; Department of Neurology, Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg-Eppendorf, Hamburg, 20251, Germany.
Massarweh G; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Soucy JP; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Pascoal TA; Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, 15213, USA.
Stomrud E; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Palmqvist S; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Mattsson-Carlgren N; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.; Wallenberg Center for Molecular Medicine, Lund University, Lund, Sweden.
Gauthier S; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada.; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, S-431 80, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 6BG, UK.; UK Dementia Research Institute at UCL, London, WC1N 6BG, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53792, USA.
Hansson O; Department of Clinical Sciences Malmö, Clinical Memory Research Unit, Lund University, Lund, Sweden.; Memory Clinic, Skåne University Hospital, Malmö, Sweden.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, S-431 80, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, S-431 80, Sweden.
Rosa-Neto P; Translational Neuroimaging Laboratory, McGill University Research Centre for Studies in Aging, Alzheimer's Disease Research Unit, Douglas Research Institute, Le Centre Intégré Universitaire de Santé Et de Services Sociaux (CIUSSS) de l'Ouest-de-L'Île-de-Montréal, 6875 La Salle Blvd - FBC Room 3149, Montréal, Québec, H4H 1R3, Canada. .; Department of Neurology and Neurosurgery, McGill University, Montreal, QC, H3A 2B4, Canada. .; Pokaż więcej
Źródło:: Molecular neurodegeneration [Mol Neurodegener] 2024 Jan 07; Vol. 19 (1), pp. 2. Date of Electronic Publication: 2024 Jan 07.
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*/diagnosis
Humans ; Amyloidogenic Proteins ; Immunoassay ; Mass Spectrometry ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis.
Autorzy:: Gaetani L; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Bellomo G; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Di Sabatino E; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Sperandei S; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Mancini A; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Blennow K; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 431 41 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 41 Mölndal, Sweden.
Zetterberg H; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 431 41 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 41 Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London WC1E 6BT, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong 518172, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53792, USA.
Parnetti L; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.
Di Filippo M; Section of Neurology, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Dec 21; Vol. 25 (1). Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:: Journal Article
MeSH Terms:: Multiple Sclerosis*/diagnosis
Multiple Sclerosis, Relapsing-Remitting*/diagnosis
Humans ; Oligoclonal Bands ; Axons ; Biological Assay

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: 14-3-3 [Formula: see text]-reported early synaptic injury in Alzheimer's disease is independently mediated by sTREM2.
Autorzy:: Woo MS; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg Eppendorf, Falkenried 94, 20251 Hamburg, Germany.
Nilsson J; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.
Therriault J; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC H4H 1R3 Canada.
Rahmouni N; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.
Brinkmalm A; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.
Benedet AL; Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 40530 Mölndal, Sweden.
Ashton NJ; Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 40530 Mölndal, Sweden.; Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, 40530 Gothenburg, Sweden.
Macedo AC; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC H4H 1R3 Canada.
Servaes S; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.
Wang YT; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC H4H 1R3 Canada.
Tissot C; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.
Arias JF; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.
Hosseini SA; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.
Chamoun M; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC H4H 1R3 Canada.
Lussier FZ; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC H4H 1R3 Canada.
Karikari TK; Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 40530 Mölndal, Sweden.
Stevenson J; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.
Mayer C; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg Eppendorf, Falkenried 94, 20251 Hamburg, Germany.
Ferrari-Souza JP; Department of Neurology and Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213 PA USA.; Graduate Program in Biological Sciences: Biochemistry, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 91501-970 Brazil.
Kobayashi E; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC H4H 1R3 Canada.
Massarweh G; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC H4H 1R3 Canada.
Friese MA; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Center Hamburg Eppendorf, Falkenried 94, 20251 Hamburg, Germany.
Pascoal TA; Department of Neurology and Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213 PA USA.
Gauthier S; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC H4H 1R3 Canada.
Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.; Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 40530 Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, WC1E 6BT UK.; UK Dementia Research Institute at UCL, London, WC1E 6BT UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, 518172 China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53726 USA.
Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 40530 Gothenburg, Sweden.; Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 40530 Mölndal, Sweden.
Rosa-Neto P; Translational Neuroimaging Laboratory, McGill Research Centre for Studies in Aging, 6875 La Salle Blvd, FBC Room 3149, Montreal, QC H4H 1R3 Canada.; Department of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montreal, QC H4H 1R3 Canada.; Pokaż więcej
Źródło:: Journal of neuroinflammation [J Neuroinflammation] 2023 Nov 24; Vol. 20 (1), pp. 278. Date of Electronic Publication: 2023 Nov 24.
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*/pathology
Amyloidosis*
Humans ; Amyloid beta-Peptides/cerebrospinal fluid ; Biomarkers/cerebrospinal fluid ; Gliosis ; tau Proteins/metabolism ; 14-3-3 Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: CSF, Blood, and MRI Biomarkers in Skogholt's Disease-A Rare Neurodegenerative Disease in a Norwegian Kindred.
Autorzy:: Aspli KT; Department of Neurology, Innlandet Hospital Trust, 2381 Lillehammer, Norway.; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.
Aaseth JO; Research Department, Innlandet Hospital Trust, 2381 Brumunddal, Norway.
Holmøy T; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.; Department of Neurology, Akershus University Hospital, 1478 Nordbyhagen, Norway.
Blennow K; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 43153 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 43153 Mölndal, Sweden.; Institut du Cerveau et de la Moelle Épinière (ICM), Pitié-Salpêtrière Hospital, Sorbonne Université, 75651 Paris, France.; First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei 230001, China.
Zetterberg H; Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, 43153 Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 43153 Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.; UK Dementia Research Institute, University College London, London WC1N 3AR, UK.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53706, USA.
Kirsebom BE; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.; Department of Neurology, University Hospital of North Norway, 9019 Tromsø, Norway.; Department of Psychology, Faculty of Health Sciences, UiT, the Arctic University of Norway, 9019 Tromsø, Norway.
Fladby T; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.; Department of Neurology, Akershus University Hospital, 1478 Nordbyhagen, Norway.
Selnes P; Institute of Clinical Medicine, University of Oslo, 0316 Oslo, Norway.; Department of Research, Akershus University Hospital, 1478 Nordbyhagen, Norway.; Pokaż więcej
Źródło:: Brain sciences [Brain Sci] 2023 Oct 26; Vol. 13 (11). Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Association between ventricular CSF biomarkers and outcome after shunt surgery in idiopathic normal pressure hydrocephalus.
Autorzy:: Grønning R; Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, Sahlgrenska University Hospital, 41345, Gothenburg, Sweden. .
Jeppsson A; Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, Sahlgrenska University Hospital, 41345, Gothenburg, Sweden.
Hellström P; Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, Sahlgrenska University Hospital, 41345, Gothenburg, Sweden.
Laurell K; Department of Medical Sciences, Neurology, Uppsala University, Uppsala, Sweden.
Farahmand D; Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, Sahlgrenska University Hospital, 41345, Gothenburg, Sweden.
Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
Blennow K; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Mölndal, Sweden.
Wikkelsø C; Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, Sahlgrenska University Hospital, 41345, Gothenburg, Sweden.
Tullberg M; Hydrocephalus Research Unit, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Blå Stråket 7, Sahlgrenska University Hospital, 41345, Gothenburg, Sweden.; Pokaż więcej
Źródło:: Fluids and barriers of the CNS [Fluids Barriers CNS] 2023 Oct 25; Vol. 20 (1), pp. 77. Date of Electronic Publication: 2023 Oct 25.
Typ publikacji:: Journal Article
MeSH Terms:: Hydrocephalus, Normal Pressure*/surgery
Hydrocephalus, Normal Pressure*/pathology
Alzheimer Disease*
Humans ; Amyloid beta-Peptides/metabolism ; Neurogranin ; tau Proteins/metabolism ; Amyloid beta-Protein Precursor/metabolism ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status.
Autorzy:: Gallagher RL; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Medical Scientist Training Program, University of Wisconsin-Madison, Madison, WI, USA.; Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.
Koscik RL; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.; Wisconsin Alzheimer's Institute, Madison, WI, USA.
Moody JF; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.; Wisconsin Alzheimer's Institute, Madison, WI, USA.
Vogt NM; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Medical Scientist Training Program, University of Wisconsin-Madison, Madison, WI, USA.; Neuroscience Training Program, University of Wisconsin-Madison, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.
Adluru N; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.; Waisman Research Center, Madison, WI, USA.
Kecskemeti SR; Waisman Research Center, Madison, WI, USA.
Van Hulle CA; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.
Chin NA; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.
Asthana S; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.; Veterans Administration, Madison, WI, USA.
Kollmorgen G; Roche Diagnostics GmbH, Penzberg, Germany.
Suridjan I; Roche Diagnostics International Ltd, Rotkreuz, Switzerland.
Carlsson CM; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.; Wisconsin Alzheimer's Institute, Madison, WI, USA.; Veterans Administration, Madison, WI, USA.
Johnson SC; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.; Wisconsin Alzheimer's Institute, Madison, WI, USA.; Veterans Administration, Madison, WI, USA.
Dean DC 3rd; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Waisman Research Center, Madison, WI, USA.
Zetterberg H; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Alexander AL; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA.; Waisman Research Center, Madison, WI, USA.
Bendlin BB; School of Medicine and Public Health, University of Wisconsin, Madison, WI, USA. .; Wisconsin Alzheimer's Disease Research Center, Madison, WI, USA. .; Wisconsin Alzheimer's Institute, Madison, WI, USA. .; Pokaż więcej
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2023 Oct 17; Vol. 15 (1), pp. 180. Date of Electronic Publication: 2023 Oct 17.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Alzheimer Disease*/pathology
Cognitive Dysfunction*/diagnosis
Humans ; Neuroimaging/methods ; Biomarkers/cerebrospinal fluid ; tau Proteins/cerebrospinal fluid ; Amyloid beta-Peptides/cerebrospinal fluid

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Blood biomarkers and neurodegeneration in individuals exposed to repetitive head impacts.
Autorzy:: Bernick C; Neurological Institute, Cleveland Clinic, Las Vegas, NV, USA. .
Shan G; Department of Biostatistics, University of Florida, Gainesville, FL, USA.
Ritter A; Neurological Institute, Cleveland Clinic, Las Vegas, NV, USA.
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Lantero-Rodriguez J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Snellman A; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin, University of Wisconsin-Madison, Madison, WI, USA.; Pokaż więcej
Źródło:: Alzheimer's research & therapy [Alzheimers Res Ther] 2023 Oct 12; Vol. 15 (1), pp. 173. Date of Electronic Publication: 2023 Oct 12.
Typ publikacji:: Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
MeSH Terms:: Brain*/diagnostic imaging
Brain*/pathology
Cognitive Dysfunction*/pathology
Humans ; Adult ; Middle Aged ; Cognition ; Biomarkers ; Neuropsychological Tests

Raport

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
Autorzy:: Neumann A; Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.; Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Center, Rotterdam, Netherlands.
Ohlei O; Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, Ratzeburger Allee 160, V50.2M, Lübeck, 23562, Germany.
Küçükali F; Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Bos IJ; Netherlands Institute for Health Services Research, Utrecht, Netherlands.
Timsina J; Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.; NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA.
Vos S; Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands.
Prokopenko D; Genetics and Aging Unit and McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Tijms BM; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
Andreasson U; Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Blennow K; Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Vandenberghe R; Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium.; Neurology Service, University Hospital Leuven, Leuven, Belgium.
Scheltens P; Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
Teunissen CE; Neurochemistry Laboratory, Department of Clinical Chemistry, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, Netherlands.
Engelborghs S; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.; Department of Neurology and Memory Clinic, Universitair Ziekenhuis Brussel (UZ Brussel) and Center for Neurosciences (C4N), Vrije Universiteit Brussel (VUB), Brussels, Belgium.
Frisoni GB; Memory Center, Department of Rehabilitation and Geriatrics, Geneva University and University Hospitals, Geneva, Switzerland.
Blin O; Clinical Pharmacology & Pharmacovigilance Department, Marseille University Hospital, Marseille, France.
Richardson JC; Neurosciences Therapeutic Area, GlaxoSmithKline R&D, Stevenage, UK.
Bordet R; Neuroscience & Cognition, CHU de Lille, University of Lille, Inserm, France.
Lleó A; Memory Unit, Neurology Department, Hospital de Sant Pau, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Alcolea D; Memory Unit, Neurology Department, Hospital de Sant Pau, Barcelona, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
Popp J; Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zürich, Zurich, Switzerland.; Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.
Marsh TW; Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.; NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA.; Division of Biology & Biomedical Sciences, Washington University in St. Louis, St Louis, MO, USA.
Gorijala P; Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.; NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA.
Clark C; Department of Psychiatry, Psychotherapy and Psychosomatics, University of Zürich, Zurich, Switzerland.
Peyratout G; Department of Psychiatry, University Hospital of Lausanne, Lausanne, Switzerland.
Martinez-Lage P; Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain.
Tainta M; Center for Research and Advanced Therapies, CITA-Alzheimer Foundation, San Sebastian, Spain.; Zumarraga Hospital, Osakidetza, Integrated Health Organization (OSI) Goierri-Urola Garia, Basque Country, Spain.
Dobson RJB; Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, Boston, UK.; NIHR BioResource Centre Maudsley, NIHR Maudsley Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust (SLaM) & Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London, London, UK.; Health Data Research UK London, University College London, London, UK.; Institute of Health Informatics, University College London, London, UK.; The National Institute for Health Research University College London Hospitals Biomedical Research Centre, University College London, London, UK.
Legido-Quigley C; Steno Diabetes Center, Copenhagen, Denmark.; Institute of Pharmaceutical Science, King's College London, London, UK.
Van Broeckhoven C; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.; Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.
Tanzi RE; Genetics and Aging Unit and McCance Center for Brain Health, Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Ten Kate M; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, Netherlands.; Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands.
Lill CM; Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, Ratzeburger Allee 160, V50.2M, Lübeck, 23562, Germany.; Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.; Ageing Epidemiology Research Unit, School of Public Health, Imperial College, London, UK.
Barkhof F; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands.; Queen Square Institute of Neurology and Centre for Medical Image Computing, University College London, London, UK.
Cruchaga C; Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.; NeuroGenomics and Informatics Center, Washington University School of Medicine, St Louis, MO, USA.; Hope Center for Neurological Disorders, Washington University School of Medicine, St Louis, MO, USA.
Lovestone S; Janssen Medical Ltd, Wycombe, UK.; Department of Psychiatry, University of Oxford, Oxford, UK.
Streffer J; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.; AC Immune SA, Lausanne, Switzerland.; Janssen R&D, LLC, Beerse, Belgium.
Zetterberg H; Department of Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK.; UK Dementia Research Institute, University College London, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.
Visser PJ; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.; Alzheimer Centrum Limburg, Maastricht University, Maastricht, Netherlands.; Alzheimer Center and Department of Neurology, VU University Medical Center, Amsterdam, Netherlands.
Sleegers K; Complex Genetics of Alzheimer's Disease Group, VIB Center for Molecular Neurology, VIB, Antwerp, Belgium.; Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
Bertram L; Lübeck Interdisciplinary Platform for Genome Analytics (LIGA), University of Lübeck, Ratzeburger Allee 160, V50.2M, Lübeck, 23562, Germany. .; Centre for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway. .; Pokaż więcej
Corporate Authors:: EMIF-AD & ADNI study group
Źródło:: Genome medicine [Genome Med] 2023 Oct 04; Vol. 15 (1), pp. 79. Date of Electronic Publication: 2023 Oct 04.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Alzheimer Disease*/genetics
Alzheimer Disease*/pathology
Humans ; Female ; Male ; Genome-Wide Association Study ; tau Proteins/genetics ; Biomarkers ; Inflammation ; Apolipoproteins E/genetics ; Membrane Proteins/genetics ; Nerve Tissue Proteins/genetics ; Receptors, N-Methyl-D-Aspartate/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: A microglial activity state biomarker panel differentiates FTD-granulin and Alzheimer's disease patients from controls.
Autorzy:: Pesämaa I; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Graduate School of Systemic Neurosciences (GSN), Ludwig-Maximilians-University Munich, Munich, Germany.; Department of Psychiatry & Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Müller SA; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Robinson S; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Graduate School of Systemic Neurosciences (GSN), Ludwig-Maximilians-University Munich, Munich, Germany.; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig-Maximilians- University Munich, Munich, Germany.
Darcher A; Epileptology, University Hospital Bonn, Bonn, Germany.
Paquet D; Institute for Stroke and Dementia Research, University Hospital Munich, Ludwig-Maximilians- University Munich, Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), Munich, Germany.
Zetterberg H; Department of Psychiatry & Neurochemistry, Institute of Neuroscience & Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.; Clinical Neurochemistry Laboratory, Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin, University of Wisconsin-Madison, Madison, WI, USA.
Lichtenthaler SF; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany.; Neuroproteomics, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), Munich, Germany.
Haass C; German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany. .; Munich Cluster for Systems Neurology (Synergy), Munich, Germany. .; Biomedical Centre (BMC), Faculty of Medicine, Ludwig-Maximilians-University Munich, Munich, Germany. .; Pokaż więcej
Źródło:: Molecular neurodegeneration [Mol Neurodegener] 2023 Sep 29; Vol. 18 (1), pp. 70. Date of Electronic Publication: 2023 Sep 29.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Alzheimer Disease*/metabolism
Frontotemporal Dementia*/genetics
Frontotemporal Dementia*/metabolism
Induced Pluripotent Stem Cells*/metabolism
Animals ; Humans ; Mice ; Amyloid beta-Peptides/metabolism ; Amyloidogenic Proteins/metabolism ; Biomarkers/metabolism ; Culture Media, Conditioned/pharmacology ; Granulins/metabolism ; Membrane Glycoproteins/genetics ; Mice, Knockout ; Microglia/metabolism ; Proteome ; Proteomics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study.
Autorzy:: Sievert T; Department of Clinical Medicine, Anaesthesiology and Intensive Care, Lund University, Lund, SE-22185, Sweden. .; Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, SE-22185, Sweden. .
Didriksson I; Department of Clinical Medicine, Anaesthesiology and Intensive Care, Lund University, Lund, SE-22185, Sweden.; Department of Intensive and Perioperative Care, Skåne University Hospital, Malmö, SE-20502, Sweden.
Spångfors M; Department of Clinical Medicine, Anaesthesiology and Intensive Care, Lund University, Lund, SE-22185, Sweden.; Department of Anaesthesia and Intensive Care, Kristianstad Hospital, Kristianstad, SE-29133, Sweden.
Lilja G; Department of Neurology, Skåne University Hospital, Lund, SE-22185, Sweden.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, SE-43180, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, SE-43180, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Mölndal, SE-43180, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, SE-43180, Sweden.; Department of Neurodegenerative Disease, University College London Institute of Neurology, London, United Kingdom.; United Kingdom Dementia Research Institute, University College London, London, United Kingdom.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, United States of America.
Frigyesi A; Department of Clinical Medicine, Anaesthesiology and Intensive Care, Lund University, Lund, SE-22185, Sweden.; Department of Intensive and Perioperative Care, Skåne University Hospital, Lund, SE-22185, Sweden.
Friberg H; Department of Clinical Medicine, Anaesthesiology and Intensive Care, Lund University, Lund, SE-22185, Sweden.; Department of Intensive and Perioperative Care, Skåne University Hospital, Malmö, SE-20502, Sweden.; Pokaż więcej
Źródło:: Intensive care medicine experimental [Intensive Care Med Exp] 2023 Sep 28; Vol. 11 (1), pp. 66. Date of Electronic Publication: 2023 Sep 28.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease.
Autorzy:: Balusu S; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Horré K; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Thrupp N; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Craessaerts K; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Snellinx A; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Serneels L; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
T'Syen D; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Chrysidou I; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Arranz AM; Achucarro Basque Center for Neuroscience, 48940 Leioa, Spain.; Ikerbasque Basque Foundation for Science, 48009 Bilbao, Spain.
Sierksma A; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Simrén J; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 80 Möndal, Sweden.; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, 431 80 Möndal, Sweden.
Karikari TK; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 80 Möndal, Sweden.; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, 431 80 Möndal, Sweden.; Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Zetterberg H; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 80 Möndal, Sweden.; Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, 431 80 Möndal, Sweden.; Department of Neurodegenerative Disease, University College London (UCL) Institute of Neurology, London WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London WC1E 6BT, UK.; Hong Kong Center for Neurodegenerative Diseases, Hong Kong, China.
Chen WT; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
Thal DR; Laboratory for Neuropathology, Department of Imaging and Pathology, Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.; Department of Pathology, University Hospital Leuven, 3000 Leuven, Belgium.
Salta E; Laboratory of Neurogenesis and Neurodegeneration, Netherlands Institute for Neuroscience, 1105BA Amsterdam, Netherlands.
Fiers M; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.; UK Dementia Research Institute at UCL, London WC1E 6BT, UK.
De Strooper B; VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.; Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.; UK Dementia Research Institute at UCL, London WC1E 6BT, UK.; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2023 Sep 15; Vol. 381 (6663), pp. 1176-1182. Date of Electronic Publication: 2023 Sep 14.
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*/pathology
Necroptosis*/genetics
Neurons*/pathology
RNA, Long Noncoding*/genetics
RNA, Long Noncoding*/metabolism
Animals ; Humans ; Mice ; Heterografts ; Protein Kinases/genetics ; Receptor-Interacting Protein Serine-Threonine Kinases/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer's disease with multi-modal PET and plasma GFAP.
Autorzy:: Chiotis K; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.; Department of Neurology, Karolinska University Hospital, Stockholm, Sweden.
Johansson C; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.; Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden.
Rodriguez-Vieitez E; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden.; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.
Ashton NJ; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Centre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.; Institute of Psychiatry, Psychology & Neuroscience, King's College London, Maurice Wohl Clinical Neuroscience Institute, London, UK.; NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK.; UK Dementia Research Institute at UCL, London, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, School of Medicine and Public Health, University of Wisconsin, University of Wisconsin-Madison, Madison, WI, USA.
Graff C; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden.; Unit for Hereditary Dementia, Karolinska University Hospital-Solna, Solna, Sweden.
Nordberg A; Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden. .; Theme Inflammation and Aging, Karolinska University Hospital, Stockholm, Sweden. .; Pokaż więcej
Źródło:: Molecular neurodegeneration [Mol Neurodegener] 2023 Sep 12; Vol. 18 (1), pp. 60. Date of Electronic Publication: 2023 Sep 12.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Alzheimer Disease*/genetics
Gliosis*
Humans ; Amyloid beta-Peptides ; Fluorodeoxyglucose F18 ; Glial Fibrillary Acidic Protein ; Inflammation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: A Multiplexed Urinary Biomarker Panel Has Potential for Alzheimer's Disease Diagnosis Using Targeted Proteomics and Machine Learning.
Autorzy:: Hällqvist J; Translational Mass Spectrometry Research Group, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Pinto RC; Faculty of Medicine, School of Public Health, Imperial College London, London SW7 2BX, UK.
Heywood WE; Translational Mass Spectrometry Research Group, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Cordey J; Translational Mass Spectrometry Research Group, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Foulkes AJM; National Hospital for Neurology and Neurosurgery, Queen Square London, London WC1N 3BG, UK.
Slattery CF; Darent Valley Hospital, Dartford DA2 8DA, UK.
Leckey CA; Translational Mass Spectrometry Research Group, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.; Dementia Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Murphy EC; Dementia Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, S-431 80 Mölndal, Sweden.; UK Dementia Research Institute, UCL, London WC1E 6BT, UK.
Schott JM; National Hospital for Neurology and Neurosurgery, Queen Square London, London WC1N 3BG, UK.; Dementia Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.
Mills K; Translational Mass Spectrometry Research Group, Genetics and Genomic Medicine, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK.
Paterson RW; National Hospital for Neurology and Neurosurgery, Queen Square London, London WC1N 3BG, UK.; Darent Valley Hospital, Dartford DA2 8DA, UK.; Dementia Research Centre, UCL Queen Square Institute of Neurology, London WC1N 3BG, UK.; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, S-431 80 Mölndal, Sweden.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 06; Vol. 24 (18). Date of Electronic Publication: 2023 Sep 06.
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*/diagnosis
Urinary Tract*
Humans ; Proteomics ; Machine Learning ; Biomarkers ; Neoplasm Proteins ; Intracellular Signaling Peptides and Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer's Disease.
Autorzy:: Kulczyńska-Przybik A; Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.
Dulewicz M; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 405 30 Gothenburg, Sweden.
Doroszkiewicz J; Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.
Borawska R; Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.
Słowik A; Department of Neurology, Jagiellonian University, 30-688 Kraków, Poland.
Zetterberg H; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 405 30 Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 80 Mölndal, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.; UK Dementia Research Institute at UCL, London WC1N 3AR, UK.; Hong Kong Center for Neurodegenerative Diseases, Clear Water Bay, Hong Kong, China.; Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI 53792-2460, USA.
Hanrieder J; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 405 30 Gothenburg, Sweden.; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.; SciLifeLab, University of Gothenburg, 405 30 Gothenburg, Sweden.
Blennow K; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy at the University of Gothenburg, 405 30 Gothenburg, Sweden.; Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 80 Mölndal, Sweden.
Mroczko B; Department of Neurodegeneration Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.; Department of Biochemical Diagnostics, Medical University of Bialystok, 15-269 Bialystok, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Aug 24; Vol. 24 (17). Date of Electronic Publication: 2023 Aug 24.
Typ publikacji:: Journal Article
MeSH Terms:: Alzheimer Disease*/diagnosis
Alzheimer Disease*/metabolism
Humans ; Biomarkers ; Central Nervous System ; Chemokine CXCL12 ; Chitinase-3-Like Protein 1 ; Neurogranin ; Chemokine CX3CL1

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Zetterberg, Henrik"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język